# Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

> **NCT00145431** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 41 (actual)

## Conditions studied

- Hyperlipoproteinemia Type III

## Interventions

- **DRUG:** torcetrapib/atorvastatin
- **DRUG:** atorvastatin
- **DRUG:** fenofibrate

## Key facts

- **NCT ID:** NCT00145431
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2012-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145431, "Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00145431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*